StockNews.com Begins Coverage on Intra-Cellular Therapies (NASDAQ:ITCI)
Equities researchers at StockNews.com initiated coverage on shares of Intra-Cellular Therapies (NASDAQ:ITCI – Get Free Report) in a note issued to investors on Thursday. The firm set a “hold” rating on the biopharmaceutical company’s stock. A number of other equities analysts have also recently weighed in on ITCI. Royal Bank of Canada reaffirmed a “sector […]
Equities researchers at StockNews.com initiated coverage on shares of Intra-Cellular Therapies (NASDAQ:ITCI – Get Free Report) in a note issued to investors on Thursday. The firm set a “hold” rating on the biopharmaceutical company’s stock. A number of other equities analysts have also recently weighed in on ITCI. Royal Bank of Canada reaffirmed a “sector […]
